A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Clinical trial NCT01440361 · WITHDRAWN

Trial details

NCT number: NCT01440361
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2013-03-01
Primary completion: 2015-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.